AI Research for Leukemia (2020) [Video]

Peter M. Riedell, MD, University of Chicago Medicine, Chicago, IL, shares updates from the Phase III ZUMA-7 trial (NCT03391466) of the anti CD19 axicabtagene ciloleucel (axi-cel), a chimeric antigen receptor (CAR) T-cell therapy in patients with relapsed/refractory (r/r) large B-cell lymphoma (LBCL). A superior event-free survival and overall survival were reported in the axi-cel arm and the findings corroborate with data from the Phase III TRANSFORM trial (NCT03575351), demonstrating the potential of CAR T-cell therapy as a second-line option for LBCL. This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.

As Omicron cases rise, shielding patients who have weakened immune systems are calling for more support and guidance.Juliet Roberston, from Inverurie, says she feels “forgotten about” after she was diagnosed with blood cancer last December.Despite the roll out of the vaccine Ms Robertson has been shielding ever since as her body is unable to fend off viruses like Covid-19.

A 7-year-old Woodland boy diagnosed with leukemia wished to meet Santa Claus and have a hamburger dinner at the North Poleand that wish was granted.

Seneca Valley High School's football team is learning the greatest lessons in life this year.